| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/18/1993 | US5212295 Monomers for preparation of oligonucleotides having chiral phosphorus linkages |
| 05/13/1993 | WO1993009236A1 Myogenic vector systems |
| 05/13/1993 | WO1993009230A1 Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids |
| 05/13/1993 | WO1993009228A1 TGF-β TYPE RECEPTOR cDNAS AND USES THEREFOR |
| 05/13/1993 | WO1993009222A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 05/13/1993 | WO1993009221A1 Targeted delivery of virus vector to mammalian cells |
| 05/13/1993 | WO1993008843A1 Trapped cells and use thereof as a drug |
| 05/13/1993 | CA2122991A1 Transfection of vertebrate cells by homologous recombination |
| 05/13/1993 | CA2122617A1 Myogenic vector systems |
| 05/13/1993 | CA2122491A1 Tgf-.beta. type receptor cdnas and uses therefor |
| 05/13/1993 | CA2099246A1 Trapped cells and use thereof as a drug |
| 05/11/1993 | US5210076 Methods of treating Parkinson's disease using melanin |
| 05/09/1993 | WO1993009239A1 Adeno-associated virus-2 basal vectors |
| 05/05/1993 | EP0539573A1 Genomic modifications with homologous dna targeting |
| 05/05/1993 | EP0500799A4 Particle-mediated transformation of animal tissue cells |
| 05/05/1993 | CN1071586A Receptor of mutation growth factor use as pharmaceutical and application for treating cancer |
| 05/01/1993 | WO1993008844A1 Transformant cells for the prophylaxis or treatment of diseases caused by viruses, particularly pathogenic retroviruses |
| 05/01/1993 | CA2099247A1 Transformant cells for the prophylaxis or treatment of diseases caused by viruses, particularly pathogenic retroviruses |
| 04/29/1993 | WO1993007906A1 Lymphokine gene therapy of cancer |
| 04/29/1993 | CA2121127A1 Lymphokine gene therapy of cancer |
| 04/28/1993 | EP0538952A1 Antitumor Vaccines Comprising IL-6 Transfected Cells |
| 04/28/1993 | EP0538496A1 Recombinant fowlpox virus with intact FPV-tk-gene |
| 04/28/1993 | CN1071457A Conjugates for introducing nucleic acid into higher eucaryotic cells |
| 04/21/1993 | EP0537299A1 Oligonucleotide-transport agent disulfide conjugates |
| 04/17/1993 | WO1993008292A1 Particle-mediated transformation of animal somatic cells |
| 04/17/1993 | CA2098599A1 Particle-mediated transformation of animal somatic cells |
| 04/15/1993 | WO1993007283A1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 04/15/1993 | WO1993007281A1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors |
| 04/15/1993 | WO1993006867A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 04/15/1993 | CA2120370A1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors |
| 04/14/1993 | EP0536563A1 Nuclear inhibitor I-92 and its use for the production of a medicament |
| 04/14/1993 | EP0536234A1 Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof |
| 04/14/1993 | CN1070946A Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 04/01/1993 | WO1993006223A1 Viral recombinant vectors for expression in muscle cells |
| 04/01/1993 | WO1993006123A1 Human cyclin e |
| 04/01/1993 | WO1993005817A1 Transgenic mhc class i and class ii antigen-deficient mammals |
| 04/01/1993 | WO1993005815A1 Synthetic transfection vectors |
| 04/01/1993 | WO1993005783A1 Diagnosis and therapy for parkinson's disease |
| 04/01/1993 | WO1993001286A3 Localized oligonucleotide therapy |
| 04/01/1993 | CA2116130A1 Diagnosis and therapy for parkinson's disease |
| 03/31/1993 | EP0534097A2 Use of NADH or NADPH against cancer or AIDS |
| 03/31/1993 | EP0533846A1 The ciliary neurotrophic factor receptor |
| 03/30/1993 | US5198359 Recombinant protein receptor for il-2 |
| 03/24/1993 | EP0532525A1 New protein-polycation conjugates. |
| 03/18/1993 | WO1993005162A1 Method for delivering nucleic acids into cells |
| 03/18/1993 | WO1993005157A1 Ribosomal structure derived from the genomic rna structure of the delta hepatitus virus |
| 03/18/1993 | WO1993005148A1 Mutated growth factor receptor as medicament and its use for treating cancer |
| 03/18/1993 | WO1993005147A1 Defective interfering hiv particles with chimeric cd4-env |
| 03/18/1993 | WO1993004701A1 Targeted delivery of poly- or oligonucleotides to cells |
| 03/18/1993 | WO1993002654A3 A method of inducing hemoglobin synthesis in red blood cells and uses therefor |
| 03/18/1993 | CA2117073A1 Mutated growth factor receptor as a drug and its use for the treatment of cancer |
| 03/18/1993 | CA2116676A1 Method for delivering nucleic acids into cells |
| 03/18/1993 | CA2116107A1 Targeted delivery of poly-or oligonucleotides to cells |
| 03/17/1993 | EP0531436A1 Sequence-specific nonphotoactivated crosslinking agents which bind to the major groove of duplex dna |
| 03/11/1993 | DE4129533A1 Mutierter wachstumsfaktorrezeptor als arzneimittel und seine verwendung zur behandlung von krebs A mutant growth factor receptor as a medicament and its use for treatment of cancer |
| 03/10/1993 | EP0530265A1 Dna encoding human 5-ht 1d? receptors and uses thereof |
| 03/09/1993 | US5192659 DNA and primers for genetic engineering |
| 03/04/1993 | WO1993004167A1 In vivo gene transfer using implanted retroviral producer cells |
| 03/04/1993 | WO1993003770A1 Method and compositions for cellular reprogramming |
| 03/04/1993 | WO1993003769A1 Adenovirus mediated transfer of genes to the gastrointestinal tract |
| 03/04/1993 | WO1993003768A1 Isolation, growth, differentiation and genetic engineering of human muscle cells |
| 03/04/1993 | WO1993003743A1 Method of gene delivery to post-mitotic cells |
| 03/04/1993 | WO1993003736A1 Cross-linking oligonucleotides for enzyme-mediated triple strand formation |
| 03/04/1993 | WO1993003709A1 Composition and method for treating cystic fibrosis |
| 03/04/1993 | CA2116118A1 Isolation, growth, differentiation and genetic engineering of human muscle cells |
| 03/04/1993 | CA2115742A1 Adenovirus mediated transfer of genes to the gastrointestinal tract |
| 03/04/1993 | CA2115364A1 Composition and method for treating cystic fibrosis |
| 03/04/1993 | CA2115262A1 In-vivo gene transfer using implanted retroviral producer cells |
| 03/03/1993 | EP0529008A1 Modulation of gene expression through interference with rna secondary structure |
| 03/03/1993 | EP0528842A1 Methods of tissue implantation |
| 03/03/1993 | CN1069522A Intercellular adhesion molecule-3 and its binding ligands |
| 02/27/1993 | CA2076903A1 Recombinant fowlpox virus |
| 02/24/1993 | EP0528007A1 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF $g(b) CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 02/24/1993 | EP0527916A1 Antisense inhibitors of the human immunodeficiency virus |
| 02/24/1993 | EP0527818A1 Oligonucleotide modulation of arachidonic acid metabolism |
| 02/24/1993 | EP0527804A1 Gene therapy for cell proliferative diseases |
| 02/23/1993 | US5188959 Used in adoptive immunotherapy |
| 02/18/1993 | WO1993002690A1 Diagnosis and treatment of autoimmune diseases |
| 02/18/1993 | WO1993002654A2 A method of inducing hemoglobin synthesis in red blood cells and uses therefor |
| 02/18/1993 | WO1993002556A1 Cancer therapy utilizing malignant cells |
| 02/18/1993 | CA2114647A1 Diagnosis and treatment of autoimmune diseases |
| 02/18/1993 | CA2113990A1 Cancer therapy utilizing malignant cells |
| 02/17/1993 | EP0452457A4 Method of in vivo delivery of functioning foreign genes |
| 02/11/1993 | DE4126484A1 Anti-sense-RNA expression vectors - contain hybrid promoter sequences and viral DNA sequences i.e. HIV, in anti-sense direction, useful in prodn. of HIV-resistant cells |
| 02/10/1993 | EP0526452A1 Hybrid immunoglobulins |
| 02/04/1993 | WO1993002188A1 Universal donor cells |
| 02/04/1993 | WO1992019281A3 New conjugates, consisting of a glycoprotein and a nucleic acid-binding substance |
| 02/04/1993 | WO1992013950A3 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 02/03/1993 | EP0524997A1 2'-o-alkyl nucleotides and polymers containing them. |
| 02/02/1993 | CA2092571A1 Ribozyme inhibition of bcr-abl gene expression |
| 01/21/1993 | WO1993001281A1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 01/21/1993 | WO1993001275A1 NOVEL GROWTH FACTOR-RESPONSIVE PROGENITOR CELLS WHICH CAN BE PROLIFERATED $i(IN VITRO) |
| 01/21/1993 | WO1993000920A1 Use of interleukine 10 to produce drugs with a tumour-inhibiting action |
| 01/21/1993 | WO1993000909A1 Method and assay system for neurotrophin activity |
| 01/21/1993 | WO1992020316A3 Targeted delivery of genes encoding immunogenic proteins |
| 01/21/1993 | CA2112799A1 Method and assay system for neurotrophin activity |
| 01/20/1993 | EP0523189A1 Cationic lipids for intracellular delivery of biologically active molecules |
| 01/20/1993 | EP0523140A1 Reagents and methods for modulating gene expression through rna mimicry |
| 01/13/1993 | EP0522078A1 Gp75 as a tumor vaccine for melanoma |
| 01/13/1993 | EP0522054A1 Insect retinoid receptor compositions and methods |